You are here

Home » Content

Kardiyovasküler Cerrahide Trombositopeni

Thrombocytopenia In Cardivoascular Surgery

Journal Name:

  • İnönü Üniversitesi Tıp Fakültesi Dergisi

Publication Year:

  • 2008

Key Words:

Keywords (Original Language):

Author Name
Abstract (2. Language): 
Objective: We aimed to evaluate the etiology and frequency of thrombocytopenia in postoperative cardiovascular surgery patients and the complications secondary to thrombocytopenia in this patient group. Material and Methods: We retrospectively reviewed the postoperative data of 167 patients followed and treated at the cardiovascular surgery intensive care unit. The presence of thrombocytopenia was detected from blood count results in patients’ files. Etiologic factors and complications were assessed in patients possessing thrombocytopenia. Results: A thrombocyte level lower than 150,000/mm3 was accepted as thrombocytopenia. It was detected in 64 patients (%38.32). Etiologies for thrombocytopenia were the usage of low molecular weight heparin, disseminated intravascular coagulation, sepsis and septicemia, drugs other than heparin, and systemic diseases. Among these, low molecular weight heparin was the most common reason (n=34, %53.1) and in that particular patient group thrombocyte levels were higher when compared with the other factors (74.842 ± 14.246/mm3, p<0.05, r=0.168). Bleeding complications occurred secondary to thrombocytopenia and the most common hemorrhage sites were from upper gastrointestinal tract (n=12) and mucosal bleeding (n=7). Additionally, presence of diabetes mellitus significantly increased the possibility of thrombocytopenia (r=0.108, p<0.05).Conclusion: Thrombocytopenia is an important factor for mortality and morbidity for patients treated at the cardiovascular surgery intensive care unit. These patients frequently receive anticoagulant therapy in the postoperative period; thus perioperative hemostasis and postoperative close follow up of the blood parameters of these patients are critically important.
Bookmark/Search this post with
Abstract (Original Language): 
Amaç: Çalışmamızda postoperatif kardiyovasküler cerrahi hastalarında trombositopeni sıklık ve etiyolojik dağılımının belirlenmesi ve trombositopeni komplikasyonlarının irdelenmesi amaçlanmıştır. Yöntem ve Gereçler: Kardiyovasküler cerrahi yoğun bakım ünitesinde postoperatif olarak takip ve tedavisi yapılan toplam 167 hasta retrospektif olarak incelendi. Hastaların dosyalarındaki verilerle; trombositopeni varlığı, trombositopeni saptanan olgularda ise etiyolojik nedenler ve gelişen komplikasyonlar belirlendi. Bulgular: Trombosit sayısı 150,000/mm3 altındaki değerler trombositopeni olarak kabul edildi. Toplam 64 hastada (%38.32) trombositopeni tespit edildi. Trombositopeni nedenleri olarak düşük molekül ağırlıklı heparin kullanımı, yaygın damar içi koagülasyon (DİK), sepsis ve septisemi, heparin dışı diğer ilaçlar ve sistemik hastalıklar tespit edildi. Bu nedenler içinde düşük molekül ağırlıklı heparin kullanımı (n=34, %53.1) en sık rastlanılan faktördü. Ayrıca bu hastalardaki ortalama trombosit sayısı diğer nedenli trombositopenilerdeki trombosit değerleri ile karşılaştırıldığında nispeten daha yüksek seviyelerde olduğu (74.842 ± 14.246/mm3, p<0.05, r=0.168) görüldü. Trombositopeniye bağlı komplikasyon olarak kanama problemleri ile karşılaşıldı ve en sık üst gastrointestinal sistem kanamasına (n=12) ve mukozal kanamaya (n=7) rastlanıldı. Ayrıca değerlendirilmeye alınan diyabetik hastalarda trombositopeni gelişimi anlamlı olarak daha sıktı (r=0.108, p<0.05). Sonuç: Kardiyovasküler cerrahi yoğun bakım hastalarında trombositopeni önemli bir mortalite ve morbidite nedenidir. Özellikle operasyon sonrası sıklıkla antikoagülan tedavi başlanan bu hastalarda peroperatif dönemde hemostaza ayrıca önem verilmeli, postoperatif yoğun bakımda ise hastaların kan parametreleri yakın takip edilmelidir.
FULL TEXT (PDF): 
PDF icon arastirmax-kardiyovaskuler-cerrahide-trombositopeni.pdf
  • 3
191-197
  • Turkish

REFERENCES

References: 

1. Vanderschueren S, de Weerdt A, Malbrain M, Vankersschaever D, Frans E, Wilmer A, Bobbaers H. Thrombocytopenia and prognosis in intensive care. Crit Care Med 2000; 28: 1871-6.
2. Crowther MA, Cook DJ, Meade MO, Griffith LE, Guyatt GH, Arnold DM, Rabat CG, Geerts WH, Warkentin TE. Thrombocytopenia in medical surgical critically ill patients: prevalence, incidence, and risk factors. J Crit Care 2005; 20: 348-53.
3. Shalansky SJ, Verma AK; Levine M, Spinelli JJ, Dodek PM. Risk markers for thrombocytopenia in critically ill patients: a prospective analysis. Pharmacotherapy 2006; 22: 803-13.
4. Yıldız Ü, Kandemir Ö, Kale A, Can B, Tokmakoğlu B, Tezcaner T, Zorlutuna Y. Fiziksel özelliklerin ameliyat sonrası kanama miktarları üzerine etkisi. Türk Göğüs Kalp Damar Cer Derg 2006;14(1):29-33.
5. Daneschvar HL, Daw H.. Heparin- induced thrombocytopenia (an overwiew). Int J Clin Pract 2007;61(1):130-7.
6. Tenberg MJ, Huisman A, Souverein PC, Schobben AF, Egberts AC, van Solinge WW. Drug- induced thrombocytopenia : a population study. Drug So 2006; 29: 713-21.
7. Gruel Y, Regina S, Poplard C. Heparin induced thrombocytopenia. Rev prat 2006; 56: 710-8.
8. deMaistre E, Gruel Y, Lanse D. Diagnosis and management of heparin induced thrombocytopenia. Anesthesist 2006; 55: 1009-28.
9. Bargues L, Foissaud V, Jault P, Samson T, Carsin H. Heparin induced thrombocytopenia : report of four cases severely burned patients. Ann Fr Anesth Reanim 2006;25(11-12):1135-9.
10. Gettings EM, Bush KA, Van Cott EM, Hurford WE. Outcome of postoperative critically ill patients with heparin induced thrombocytopenia: an observational retrospective case control study. Crit Care 2006;10(6):R161.
11. Levine RL, McCollum D, Hursting MJ. How frequently is venous thromboembolism in heparin- treated patients associated with heparin induced thrombocytopenia? Chest 2006; 130: 681-7.
12. Mahlfeld K, Franke J, Schaeper O, Kayser R, Grasshoff H. Heparin-induced thrombocytopenia as a complication of postoperative prevention of thromboembolism with unfractionated heparin/ low moleculer weight heparin after hip and knee prosthesis implantation. Unfallchirurg 2002; 105: 327-31.
13. Warkentin TE, Sheppard JA, Siqouin CS, Kohlmann T, Eichler P, Greinacher A. Gender imbalance and risk factor interactions in heparin induced thrombocytopenia. Blood 2006;108(9):2937-41.
14. Barie PS, Hydo LJ, Eachempati SR. Causes and consequences of fever complicating ciritical surgical illness. Surg Infect (Larchut) 2004; 5: 145-55.
15. Barie PS, Hydo LJ, Fischer E. Utility of illness severity scaring of prolonged surgical critical care. J Trauma 1996; 40: 513-8.
20. Matthai WH Jr. Thrombocytopenia in cardiovascular patients: diagnosis and management. Chest. 2005 Feb;127(2 Suppl):46S-52S.
16. Strauss R, Wehler M, Mehler K, Kreutzer D, Koebnick C, Hahn EG. Thrombocytopenia in patients in the medical intensive care unit: bleeding prevalence, transfusion requirements, and outcome. Crit Care Med 2002; 30: 1765-71.
Yazışma Adresi:
17. Akca S, Haji Michael P, de Mendonca A, Suter P, Levi M, Vincent JL. Time course of platelet counts in critically ill patients. Crit Care Med 2002; 30: 753-6.
18. Greisshammer, M, Bangerter, M, Sauer, T, et al Etiology and clinical significance of thrombocytosis: analysis of 732 patients with an elevated platelet count. J Intern Med 1999;245,295-300.
19. Martin, JF, Daniel, TD, Towbridge, EA Acute and chronic changes in platelet volume and count after cardiopulmonary bypass induced thrombocytopenia in man. Thromb Haemost 1987;57,55

Thank you for copying data from http://www.arastirmax.com